Delivery Order SPE2DE24D0013-SPE2D625F4G3M
- Not listed
- The U.S. Defense Department's Medical Supply Chain division awarded a $23,475.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPCOV2/FLU/RSV-10, was awarded on July 29, 2025, with an ultimate completion date of August 12, 2025, and carries no set-aside designation. Work will be performed at Cepheid's Sunnyvale facility. This delivery order represents procurement of diagnostic testing...
- The U.S. Defense Department's Medical Supply Chain awarded a $6,800 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for XPCOV2/FLU/RSV-10 testing solutions. This delivery order, issued on July 18, 2025, with an ultimate completion date of July 25, 2025, carries no set-aside designation and represents procurement of diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The...
- The U.S. Defense Department's Medical Supply Chain awarded a $5,440 firm fixed-price delivery order to Cepheid Inc. on April 21, 2025, with an ultimate completion date of April 28, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic systems and test kits, will perform the work at its Sunnyvale...
- The U.S. Defense Department's Medical Supply Chain awarded a $7,480 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, on September 5, 2025, with completion targeted for September 19, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside designation and represents a continuation of Cepheid's...
- The U.S. Defense Department's Medical Supply Chain awarded a $204,000 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 22, 2025, and carries no set-aside designation. This award represents a continuation of the department's partnership with Cepheid to procure diagnostic testing solutions, specifically for...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, on September 10, 2025. The delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, carries no set-aside designation. This award represents a procurement of diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on May 19, 2025, with completion targeted for May 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV)—infectious disease testing capabilities aligned with federal pandemic preparedness and ongoing surveillance needs. The order carries no set-aside designation and...
- The U.S. Defense Logistics Agency (under the Medical Supply Chain function) awarded a $6,800 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on August 18, 2025, with an ultimate completion date of August 25, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The award reflects Cepheid's specialized expertise in providing rapid molecular diagnostic testing for...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $6,468.30 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, covers diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The award carries no set-aside designation and represents a task order under...
- The U.S. Defense Department's Medical Supply Chain awarded a $8,160 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, on September 2, 2025. This delivery order, designated 4569302270 for XPCOV2/FLU/RSV-10 testing solutions, is scheduled for completion by September 9, 2025, with work performed at the contractor's Sunnyvale facility. The award carries no small business set-aside designation and represents part of...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F4G3MDelivery Order
The U.S. Defense Department's Medical Supply Chain awarded a $6.8K firm fixed-price delivery order (Contract No. 4568007114) to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on April 23, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by April 30, 2025, and will be performed at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents a continuation of the federal government's procurement of diagnostic testing capabilities from Cepheid, a leading provider of molecular diagnostic systems and reagents to various defense and civilian health agencies. This delivery order is likely issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, most notably the $32.8M single-award IDV with the Veterans Affairs Veterans Integrated Service Network 6 or the $2.5M IDV with VA's Veterans Integrated Service Network 21. Both parent contracts provide molecular diagnostic testing system reagents and assays, including PCR testing for conditions such as COVID-19, influenza, respiratory syncytial virus (RSV), and other infectious diseases through laboratory microbiology programs. The modest delivery order value reflects a targeted procurement of diagnostic test kits or reagents for the specified pathogen panel, supporting the Defense Department's ongoing medical supply chain requirements for infectious disease diagnostics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 4/23/25 |